Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer

PURPOSE: Chronic adrenergic activation has been shown to associate with adverse clinical outcomes in cancer patients, but the underlying mechanisms are not well understood. The focus of the current study was to determine the functional and biological effects of adrenergic pathways on response to che...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Kang, Yu, Nagaraja, Archana S., Armaiz-Pena, Guillermo N., Dorniak, Piotr L., Hu, Wei, Rupaimoole, Rajesha, Liu, Tao, Gharpure, Kshipra M., Previs, Rebecca A., Hansen, Jean M., Rodriguez-Aguayo, Cristian, Ivan, Cristina, Ram, Prahlad, Sehgal, Vasudha, Lopez-Berestein, Gabriel, Lutgendorf, Susan K., Cole, Steven W., Sood, Anil K.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818718/
https://ncbi.nlm.nih.gov/pubmed/26581245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1275
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items